BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 14067605)

  • 1. [GLYCOCORTICOIDS IN THE PATHOLOGY OF ABORTION IN THE SECOND TRIMESTER OF PREGNANCY].
    RAGUCCI N; PASSALIA S
    Arch Ostet Ginecol; 1963; 68():235-50. PubMed ID: 14067605
    [No Abstract]   [Full Text] [Related]  

  • 2. Slow fetal heart rate may predict pregnancy outcome in first-trimester threatened abortion.
    Chittacharoen A; Herabutya Y
    Fertil Steril; 2004 Jul; 82(1):227-9. PubMed ID: 15237019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progesterone - induced blocking factor (PIBF) and Th(1)/Th(2) cytokine in women with threatened spontaneous abortion.
    Hudić I; Fatusić Z
    J Perinat Med; 2009; 37(4):338-42. PubMed ID: 19290853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The detection of anti-beta2-glycoprotein I antibodies is associated with increased risk of pregnancy loss in women with threatened abortion in the first trimester.
    Mezzesimi A; Florio P; Reis FM; D'Aniello G; Sabatini L; Razzi S; Fineschi D; Petraglia F
    Eur J Obstet Gynecol Reprod Biol; 2007 Aug; 133(2):164-8. PubMed ID: 17046145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of leukemia inhibitory factor in chorionic villi of normal early pregnancy, threatened abortion and inevitable abortion].
    Wang ZJ; Xu J
    Zhonghua Fu Chan Ke Za Zhi; 2006 Mar; 41(3):159-61. PubMed ID: 16640878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use and dosage of hormones in threatened abortion. 1952].
    Viesca B E; Iturriaga AM; Albores Culebro C
    Ginecol Obstet Mex; 2007 Aug; 75(8):488-95. PubMed ID: 18293680
    [No Abstract]   [Full Text] [Related]  

  • 7. [Utrogestan and high risk pregnancy].
    Marinov B; Petkova S; Dukovski A; Georgiev G; Garnizov T; Manchev V; Kolarov G; Iunakova M
    Akush Ginekol (Sofiia); 2004; 43(5):22-4. PubMed ID: 15518280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do serum leptin levels have a role in the prediction of pregnancy outcome in case of threatened miscarriage?
    Tommaselli GA; Di Spiezio Sardo A; Di Carlo C; Bifulco G; Cerrota G; Cirillo D; Greco E; Nappi C
    Clin Endocrinol (Oxf); 2006 Dec; 65(6):772-5. PubMed ID: 17121529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of dydrogesterone supplementation on hormonal profile and progesterone-induced blocking factor concentrations in women with threatened abortion.
    Kalinka J; Szekeres-Bartho J
    Am J Reprod Immunol; 2005 Apr; 53(4):166-71. PubMed ID: 15760377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Threatened miscarriage as a predictor of obstetric outcome.
    Johns J; Jauniaux E
    Obstet Gynecol; 2006 Apr; 107(4):845-50. PubMed ID: 16582121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors associated with presenting for abortion in the second trimester.
    Drey EA; Foster DG; Jackson RA; Lee SJ; Cardenas LH; Darney PD
    Obstet Gynecol; 2006 Jan; 107(1):128-35. PubMed ID: 16394050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obstetric outcome in women with threatened miscarriage in the first trimester.
    Wijesiriwardana A; Bhattacharya S; Shetty A; Smith N; Bhattacharya S
    Obstet Gynecol; 2006 Mar; 107(3):557-62. PubMed ID: 16507924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First-trimester bleeding and pregnancy outcome in singletons after assisted reproduction.
    De Sutter P; Bontinck J; Schutysers V; Van der Elst J; Gerris J; Dhont M
    Hum Reprod; 2006 Jul; 21(7):1907-11. PubMed ID: 16501033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Threatened abortion: A risk factor for poor pregnancy outcome, a population-based screening study.
    Weiss JL; Malone FD; Vidaver J; Ball RH; Nyberg DA; Comstock CH; Hankins GD; Berkowitz RL; Gross SJ; Dugoff L; Timor-Tritsch IE; D'Alton ME;
    Am J Obstet Gynecol; 2004 Mar; 190(3):745-50. PubMed ID: 15042008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of vaginal progesterone on pain and uterine contractility in patients with threatened abortion before twelve weeks of pregnancy.
    Palagiano A; Bulletti C; Pace MC; DE Ziegler D; Cicinelli E; Izzo A
    Ann N Y Acad Sci; 2004 Dec; 1034():200-10. PubMed ID: 15731312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First trimester threatened miscarriage treatment with human chorionic gonadotrophins: a randomised controlled trial.
    Qureshi NS; Edi-Osagie EC; Ogbo V; Ray S; Hopkins RE
    BJOG; 2005 Nov; 112(11):1536-41. PubMed ID: 16225575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors influencing the percentage of second trimester abortions in the Netherlands.
    Loeber O; Wijsen C
    Reprod Health Matters; 2008 May; 16(31 Suppl):30-6. PubMed ID: 18772081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of dydrogesterone supplementation on serum cytokine profile in women with threatened abortion.
    Kalinka J; Radwan M
    Am J Reprod Immunol; 2006 Feb; 55(2):115-21. PubMed ID: 16433830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second-trimester surgical abortion practices: a survey of National Abortion Federation members.
    O'Connell K; Jones HE; Lichtenberg ES; Paul M
    Contraception; 2008 Dec; 78(6):492-9. PubMed ID: 19014796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A critical appraisal of laws on second trimester abortion.
    Berer M
    Reprod Health Matters; 2008 May; 16(31 Suppl):3-13. PubMed ID: 18772078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.